Cdkn1c - cyclin-dependent kinase inhibitor 1C Gene
Also Known as p57; Kip2; p57KIP2
Species: Rattus norvegicus
Summary
Predicted to enable protein kinase inhibitor activity. Predicted to be involved in several processes, including negative regulation of cell cycle; positive regulation of transforming growth factor beta receptor signaling pathway; and regulation of transcription, DNA-templated. Predicted to act upstream of or within several processes, including animal organ development; genetic imprinting; and regulation of exit from Mitosis. Predicted to be located in cytoplasm and nucleus. Human ortholog(s) of this gene implicated in Beckwith-Wiedemann syndrome; IMAGe syndrome; and hyperinsulinism. Orthologous to human CDKN1C (cyclin dependent kinase inhibitor 1C). [provided by Alliance of Genome Resources, Apr 2022]
Cdkn1c Products (3)
| mRNA | Protein | Name |
|---|---|---|
| NM_001033757.1 | NP_001028929.1 | cyclin-dependent kinase inhibitor 1C isoform 1 |
| NM_001033758.1 | NP_001028930.1 | cyclin-dependent kinase inhibitor 1C isoform 2 |
| NM_182735.2 | NP_877399.2 | cyclin-dependent kinase inhibitor 1C isoform 2 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
19533683 | RGD |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cyclin-dependent kinase inhibitor 1C |
|